Clinical Trial Update: Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating alisertib in pediatric patients with various recurrent or refractory solid tumors and leukemia; study completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood Acute Lymphoblastic Leukemia
• Childhood Acute Myeloid Leukemia
• Childhood Kidney Neoplasm
• Childhood Malignant Germ Cell Tumor
• Childhood Rhabdomyosarcoma
• Childhood Soft Tissue Sarcoma
• Ewing Sarcoma Peripheral Primitive Neuroectodermal Tumor
• Hepatoblastoma
• Neuroblastoma
• Osteosarcoma

Drugs mentioned

• Alisertib (alisertib)

Snippet

Sponsor: Children's Oncology Group | Conditions: Hepatoblastoma, Previously Treated Childhood Rhabdomyosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-05